Stay updated on Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing the previous Notice about government funding (v3.4.1). These are banner-level site updates and do not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-12T02:19:27.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a government funding/operational status notice to the page and updated the version from v3.4.0 to v3.4.1, replacing the previous version reference; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T12:09:10.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display and the new field 'Last Update Submitted that Met QC Criteria'. Updated the revision note to 'Revision: v3.4.0' and made minor capitalization tweaks such as 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T09:55:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 applied; no substantive changes to the page content or layout are observed in the screenshots.
    Difference
    0.1%
    Check dated 2026-01-14T03:44:32.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new Locations section with state-level sites was added, and the previous state-specific subsections (California, Illinois, Maryland, Missouri, New York, Pennsylvania, Tennessee) were removed. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.8%
    Check dated 2025-12-23T22:05:23.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The Publications note now states that entries are automatically filled from PubMed and may not all be about the study, and the Revision is updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:44.000Z thumbnail image

Stay in the know with updates to Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Monalizumab & Cetuximab in Head & Neck Cancer Clinical Trial page.